Study of Lorlatinib in ROS1 Rearranged NSCLC

Clinical trial NCT03612154 · UNKNOWN

Trial details

NCT number: NCT03612154
Sponsor: National Cancer Center, Korea
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Nonsmall Cell Lung Cancer

Start date: 2019-05-02
Primary completion: 2022-12-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.